Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1.
Human immunodeficiency virus type 1 (HIV-1) infection is known to increase the incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma.
Parallels with other causes of immunodeficiency suggest a possible effect of HIV-1 on additional cancers.
This study was designed to determine the types and rates of cancers occurring in excess in the presence of HIV-1 infection.
We examined cancer incidence in a population-based open cohort with a high prevalence of HIV-1 infection.
The study population was never-married men aged 25-54 years who resided in San Francisco, Calif-of whom an estimated 20 000 (24%) were HIV-1 seropositive as of late 1984.
Mots-clés Pascal : Kaposi maladie, Lymphome, Incidence, Epidémiologie, Etats Unis, Amérique du Nord, Amérique, Population, SIDA, Virose, Infection, Virus HIV1, Virus immunodéficience humaine, Lentivirinae, Retroviridae, Virus, Prévalence, Haut, Homme, Peau pathologie, Tumeur maligne, Hémopathie maligne, Lymphoprolifératif syndrome, Immunopathologie, Immunodéficit
Mots-clés Pascal anglais : Kaposi sarcoma, Lymphoma, Incidence, Epidemiology, United States, North America, America, Population, AIDS, Viral disease, Infection, HIV-1 virus, Human immunodeficiency virus, Lentivirinae, Retroviridae, Virus, Prevalence, High, Human, Skin disease, Malignant tumor, Malignant hemopathy, Lymphoproliferative syndrome, Immunopathology, Immune deficiency
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0052893
Code Inist : 002B04B. Création : 09/06/1995.